People In Brief
This article was originally published in The Gray Sheet
Executive SummaryValtech Cardio: The Israeli start-up named former Boston Scientific executive Bruce H. KenKnight its new president and CEO Feb. 9. KenKnight most recently served as VP-Research and Business Development for Boston Sci's Cardiac Rhythm Management division. Earlier this month, Valtech raised $17.8 million in a Series B financing to aid its development of minimally invasive surgical and transcatheter mitral valve repair and replacement devices
You may also be interested in...
JenaValve, Predictive Biosciences, DexCom among firms with personnel news.